Skip to main content
Implanet SA logo

Implanet SA — Investor Relations & Filings

Ticker · ALIMP ISIN · FR0013470168 LEI · 969500CIMHFWNM4J4V14 PA Manufacturing
Filings indexed 266 across all filing types
Latest filing 2023-04-12 AGM Information
Country FR France
Listing PA ALIMP

About Implanet SA

http://www.implanet.com/en

Implanet is a medical technology company that designs, manufactures, and markets a range of implants and instruments for orthopedic surgery, with a specialized focus on spinal applications. The company's core offering is centered around its flagship Jazz™ platform, a latest-generation hybrid posterior fixation system intended to improve the treatment of various spinal disorders, including scoliosis. The product portfolio also includes other spinal systems such as Zeus™ and Saxxo™, Swingo™ interbody cages, Origin™ anterior cervical plates, and the Olea™ system for ultrasonic osteotomy. Additionally, Implanet provides complementary solutions like Neobone™ bone grafts. The company's products are utilized by surgeons and healthcare professionals in the field of spinal surgery.

Recent filings

Filing Released Lang Actions
Modalités de mise à disposition des documents préparatoires à l'AG
AGM Information Classification · 98% confidence The document is a press release dated April 12, 2023, primarily announcing the details for the upcoming 'Assemblée Générale Mixte' (Combined General Meeting) scheduled for May 3, 2023. It specifies the location, voting methods, and informs shareholders that the related documents are available on the company website. This content directly relates to the preparation and logistics of the Annual General Meeting. Although it also mentions the upcoming Q1 revenue release, the main focus and title concern the AGM modalities. Therefore, the most appropriate classification is AGM Information (AGM-R). The document length (3375 chars) is short, but it is an announcement *about* the AGM, not the voting results (DVA) or the proxy materials themselves (PSI), making AGM-R the best fit for general AGM logistics announcements.
2023-04-12 French
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release announcing that IMPLANET received FDA 510(k) clearance for its SqualeTM anterior cervical cage range. It details the product, strategic implications, and includes a forward-looking statement about an upcoming financial release (2023 First-Quarter Revenue). This type of announcement, focusing on a specific operational or regulatory milestone (FDA clearance) and providing immediate business context, is characteristic of a general regulatory announcement or press release that doesn't fit the specific financial report categories (10-K, IR, ER). Since it is a specific, material announcement that isn't a standard financial report, earnings release, or management change, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for significant, non-standard announcements. The document length (3474 chars) is short enough that it is not a comprehensive report itself.
2023-04-11 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated April 11, 2023, announcing that IMPLANET received FDA clearance (homologation) for its SqualeTM line of anterior cervical cages. This is a specific operational/regulatory update concerning product approval in a key market (US FDA). It is not a full financial report (10-K or IR), an earnings release (ER), a management discussion (MDA), or a proxy statement. It is a specific announcement regarding regulatory achievement and commercial outlook. While it mentions a future 'Chiffre d'affaires du 1er trimestre 2023' announcement, the core content is the FDA approval. This type of announcement, detailing a significant regulatory milestone that impacts business operations and market access, fits best under the general 'Regulatory Filings' (RNS) category as a specific, non-financial, non-management-change announcement, or potentially 'LTR' if viewed as a regulatory clearance event, but RNS is the most appropriate general regulatory announcement fallback when specific categories like DIRS, DIV, or CAP do not apply. Given the context of a press release announcing a major regulatory clearance, RNS is the most suitable general classification for this type of corporate news release.
2023-04-11 French
Modalités de mise à disposition des documents préparatoires à l'AG
AGM Information Classification · 98% confidence The document explicitly announces the date and location for the company's 'Assemblée Générale Annuelle' (Annual General Meeting) on May 3, 2023. It also mentions that shareholders are invited to consult the meeting notice ('avis de réunion valant convocation'). This content directly relates to the materials and announcements surrounding the AGM. Therefore, the appropriate classification is AGM Information (AGM-R). The document is an announcement about the meeting, not the voting results (DVA) or the proxy materials (PSI), but the core subject is the AGM itself.
2023-03-29 French
Inside Information / News release on accounts, results
Earnings Release Classification · 100% confidence The document is titled "IMPLANET reports its 2022 financial results" and contains a detailed Income Statement table comparing 2022 and 2021 figures, along with extensive commentary on revenue, gross margin, operating loss, and net result for the financial year ending December 31, 2022. This content clearly indicates a comprehensive annual financial performance review. Although it mentions the '2022 annual financial report will be available from March 23, 2023,' the current document *is* the announcement of the full-year results, which aligns best with the Annual Report (10-K) category, as it provides the core financial data, unlike a brief Earnings Release (ER) or a mere Report Publication Announcement (RPA). Given the depth of the financial tables and analysis covering the full fiscal year, 10-K is the most appropriate classification, even if it is a press release version of the annual results. FY 2022
2023-03-07 English
Informations privilégiées / Communiqué sur comptes, résultats
Earnings Release Classification · 100% confidence The document is titled "IMPLANET annonce ses résultats annuels 2022" (IMPLANET announces its 2022 annual results) and contains a detailed consolidated income statement (Compte de résultat) for the years 2022 and 2021, along with extensive commentary on revenue, gross margin, operating result, and net result for the full fiscal year ending December 31, 2022. This content strongly indicates a comprehensive annual financial disclosure. However, the final paragraph states: "Le rapport financier annuel 2022 sera disponible le 23 mars 2023 sur le site Internet de la Société." (The 2022 annual financial report will be available on March 23, 2023, on the Company's website.) Furthermore, the document structure, focusing on key highlights and financial tables released on March 7, 2023, suggests this is the initial announcement of the annual results, which aligns best with an Earnings Release (ER) or potentially a preliminary Annual Report disclosure. Given the depth of the financial tables and the explicit mention of 'résultats annuels 2022', it is more substantial than a typical ER, but it is not the final, full 10-K filing itself, as it points to a future availability date for the 'rapport financier annuel'. In the context of the provided definitions, a comprehensive annual results announcement that includes detailed financial tables but precedes the final statutory filing often falls under the scope of an Earnings Release (ER) or, if it's the primary document summarizing the year, it could be considered an Annual Report (10-K) if it were the final filing. Since it explicitly announces the *results* for the year and provides detailed figures, but also points to a future date for the full 'rapport financier annuel', it is most accurately classified as an **Earnings Release (ER)**, which is the initial announcement of periodical financial results (in this case, annual). If the document were the full statutory filing, it would be 10-K. If it were just a short notice saying the report is attached, it would be RPA. This is a detailed results announcement. FY 2022
2023-03-07 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.